Derek M. Winstanly
Président chez Renovion, Inc.
Profil
Derek M.
Winstanly currently works at Renovion, Inc., as Chairman and Quintiles Transnational Corp., as Chief Customer & Governance Officer.
Mr. Winstanly also formerly worked at Glaxo Wellcome Plc, as Chairman, President & Chief Executive Officer, GlaxoSmithKline South Africa (Pty) Ltd., as Chairman & Chief Executive Officer, Antisoma, Inc., as Director, Quintiles Transnational Holdings, Inc., as Executive VP, Chief Customer & Governance Officer, Nippon Wellcome Kk, as President, and IQVIA RDS, Inc., as Chief Customer & Governance Officer.
Mr. Winstanly received his undergraduate degree in 1972 from the University of Pretoria.
Postes actifs de Derek M. Winstanly
| Sociétés | Poste | Début |
|---|---|---|
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | 04/08/2011 |
Renovion, Inc.
 Renovion, Inc. Pharmaceuticals: MajorHealth Technology Renovion, Inc. develops therapy for chronic inflammatory airway diseases. It offers Arina-1, a nebulized therapy focused on chronic inflammatory airways diseases that is being evaluated as a twice daily nebulized therapy. The company was founded in 2013 and is headquartered in Chapel Hill, NC. | Président | - |
Anciens postes connus de Derek M. Winstanly
| Sociétés | Poste | Fin |
|---|---|---|
Nippon Wellcome Kk
 Nippon Wellcome Kk Pharmaceuticals: OtherHealth Technology Part of GSK Plc, Nippon Wellcome Kk is a Japanese company that researches, develops, manufactures, and markets pharmaceuticals. The company is located in Japan. Nippon Wellcome Kk was acquired by Glaxo Wellcome Plc on April 01, 1999. | President | - |
GlaxoSmithKline South Africa (Pty) Ltd.
 GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Directeur Général | - |
| Glaxo Wellcome Plc | Directeur Général | - |
IQVIA RDS, Inc.
 IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Quintiles Transnational Holdings, Inc.
 Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Formation de Derek M. Winstanly
| University of Pretoria | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
| Glaxo Wellcome Plc | Health Technology |
Quintiles Transnational Holdings, Inc.
Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Holdings, Inc. engages in biopharmaceutical development and commercial outsourcing. It operates through the Product Development and Integrated Healthcare Services segments. The Product Development segments provide project management and clinical monitoring, clinical trial support services, strategic planning and design, and consulting services. The Integrated Healthcare Services segments provide commercial services, communications and engagement services, real-world and late phase research, and other healthcare solutions. The company was founded by Dr. Gillings in 1982 and is headquartered in Durham, NC. | Commercial Services |
Nippon Wellcome Kk
Nippon Wellcome Kk Pharmaceuticals: OtherHealth Technology Part of GSK Plc, Nippon Wellcome Kk is a Japanese company that researches, develops, manufactures, and markets pharmaceuticals. The company is located in Japan. Nippon Wellcome Kk was acquired by Glaxo Wellcome Plc on April 01, 1999. | Health Technology |
Antisoma, Inc.
 Antisoma, Inc. Pharmaceuticals: MajorHealth Technology Antisoma, Inc. develops drugs and pharmaceuticals. The firm's products include Xanafide, Symadex, and Clomet. Its products are used in clinical and preclinical development for multiple cancer indications. The company was founded in 2001 and is headquartered Cambridge, MA. | Health Technology |
GlaxoSmithKline South Africa (Pty) Ltd.
GlaxoSmithKline South Africa (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline South Africa (Pty) Ltd. is a company based in Bryanston, South Africa. | Health Technology |
IQVIA RDS, Inc.
IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC. | Commercial Services |
Renovion, Inc.
Renovion, Inc. Pharmaceuticals: MajorHealth Technology Renovion, Inc. develops therapy for chronic inflammatory airway diseases. It offers Arina-1, a nebulized therapy focused on chronic inflammatory airways diseases that is being evaluated as a twice daily nebulized therapy. The company was founded in 2013 and is headquartered in Chapel Hill, NC. | Health Technology |
